Roger Kouyos
A Phylogeny-aware GWAS Framework to Correct for Heritable Pathogen Effects on Infectious Disease Traits.
Nadeau S, Thorball C, Kouyos R, Günthard H, Böni J, Yerly S, Perreau M, Klimkait T, Rauch A, Hirsch H, Cavassini M, Vernazza P, Bernasconi E, Fellay J, Mitov V, Stadler T. A Phylogeny-aware GWAS Framework to Correct for Heritable Pathogen Effects on Infectious Disease Traits. Mol Biol Evol 2022; 39
Aug 3, 2022A Phylogeny-aware GWAS Framework to Correct for Heritable Pathogen Effects on Infectious Disease Traits.
Aug 3, 2022Mol Biol Evol 2022; 39
Nadeau Sarah, Thorball Christian W, Kouyos Roger, Günthard Huldrych F, Böni Jürg, Yerly Sabine, Perreau Matthieu, Klimkait Thomas, Rauch Andri, Hirsch Hans H, Cavassini Matthias, Vernazza Pietro, Bernasconi Enos, Fellay Jacques, Mitov Venelin, Stadler Tanja
Response to a sexual risk reduction intervention provided in combination with hepatitis C treatment by HIV/HCV co-infected men who have sex with men: a reflexive thematic analysis
Künzler-Heule P, Fehr J, Braun D, Schmid P, Kouyos R, Lehner A, Nöstlinger C, Battegay M, Engberg S, Kocher A, Bogdanovic J, Rasi M, Schmidt A, Fierz K, Nicca D. Response to a sexual risk reduction intervention provided in combination with hepatitis C treatment by HIV/HCV co-infected men who have sex with men: a reflexive thematic analysis. BMC Infect Dis 2021; 21:319.
Apr 6, 2021Response to a sexual risk reduction intervention provided in combination with hepatitis C treatment by HIV/HCV co-infected men who have sex with men: a reflexive thematic analysis
Apr 6, 2021BMC Infect Dis 2021; 21:319
Künzler-Heule Patrizia, Fehr Jan, Braun Dominique Laurent, Schmid Patrick, Kouyos Roger, Lehner Andreas, Nöstlinger Christiana, Battegay Manuel, Engberg Sandra, Kocher Agnes, Bogdanovic Jasmina, Rasi Manuela, Schmidt Axel Jeremias, Fierz Katharina, Nicca Dunja
Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
Schoepf I, Tarr P, Fellay J, Günthard H, Kouyos R, Buvelot H, Cavassini M, Bernasconi E, Seneghini M, Thurnheer C, Marzolini C, Hasse B, Reiss P, Kootstra N, Raffenberg M, Engel T, Ledergerber B, Thorball C, Swiss HIV Cohort Study. Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study. Clin Infect Dis 2021; 73:1597-1604.
Jan 2, 2021Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
Jan 2, 2021Clin Infect Dis 2021; 73:1597-1604
Schoepf Isabella C, Tarr Philip E, Fellay Jacques, Günthard Huldrych F, Kouyos Roger, Buvelot Hélène, Cavassini Matthias, Bernasconi Enos, Seneghini Marco, Thurnheer Christine, Marzolini Catia, Hasse Barbara, Reiss Peter, Kootstra Neeltje A, Raffenberg Marieke, Engel Tanja, Ledergerber Bruno, Thorball Christian W, Swiss HIV Cohort Study
Predictors of virological failure and time to viral suppression of first line integrase inhibitor based antiretroviral treatment
Pyngottu A, Günthard H, Bernasconi E, Vernazza P, Furrer H, Stöckle M, Cavassini M, Calmy A, Yerly S, Perreau M, Hirsch H, Huber M, Kouyos R, Scherrer A, Swiss HIV Cohort Study. Predictors of virological failure and time to viral suppression of first line integrase inhibitor based antiretroviral treatment. Clin Infect Dis 2020
Oct 24, 2020Predictors of virological failure and time to viral suppression of first line integrase inhibitor based antiretroviral treatment
Oct 24, 2020Clin Infect Dis 2020
Pyngottu Ashima, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Furrer Hansjakob, Stöckle Marcel, Cavassini Matthias, Calmy Alexandra, Yerly Sabine, Perreau Matthieu, Hirsch Hans, Huber Michael, Kouyos Roger, Scherrer Alexandra U, Swiss HIV Cohort Study
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Olearo F, D'arminio Monforte A, Zazzi M, Rossetti B, Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Boeni J, Bernasconi E, Günthard H, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Cavassini M, Scherrer A, Costagliola D, Schmid P, Calmy A. Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients. Open Forum Infect Dis 2019; 6:ofz500.
Dec 8, 2019Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Dec 8, 2019Open Forum Infect Dis 2019; 6:ofz500
Olearo Flaminia, D'arminio Monforte Antonella, Zazzi Maurizio, Rossetti Barbara, Neau Didier, Bellecave Pantxika, Rijnders Bart, Reiss Peter, Wit Ferdinand, Kouyos Roger, Boeni Jürg, Bernasconi Enos, Günthard Huldrych F, Nguyen Huyen, Bonnet Fabrice, Yerly Sabine, Wandeler Gilles, Stoeckle Marcel, Cavassini Matthias, Scherrer Alexandra, Costagliola Dominique, Schmid Patrick, Calmy Alexandra
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Olearo F, D'arminio Monforte A, Zazzi M, Rossetti B, Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Boeni J, Bernasconi E, Günthard H, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Cavassini M, Scherrer A, Costagiola D, Schmid P, Calmy A. Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients. Open Forum Infect Dis 2019; 6:ofz330.
Jul 12, 2019Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Jul 12, 2019Open Forum Infect Dis 2019; 6:ofz330
Olearo Flaminia, D'arminio Monforte Antonella, Zazzi Maurizio, Rossetti Barbara, Neau Didier, Bellecave Pantxika, Rijnders Bart, Reiss Peter, Wit Ferdinand, Kouyos Roger, Boeni Jürg, Bernasconi Enos, Günthard Huldrych F, Nguyen Huyen, Bonnet Fabrice, Yerly Sabine, Wandeler Gilles, Stoeckle Marcel, Cavassini Matthias, Scherrer Alexandra, Costagiola Dominique, Schmid Patrick, Calmy Alexandra
High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men
Braun D, Fehr J, Böni J, Günthard H, Rauch A, Bernasconi E, Rougemont M, Delaloye J, Schmid P, Béguelin C, Conen A, Stöckle M, Flepp M, Grube C, Kusejko K, Kouyos R, Martin E, Hampel B, Swiss HIV Cohort Study. High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men. Clin Infect Dis 2018
Aug 13, 2018High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men
Aug 13, 2018Clin Infect Dis 2018
Braun Dominique L, Fehr Jan S, Böni Jürg, Günthard Huldrych F, Rauch Andri, Bernasconi Enos, Rougemont Mathieu, Delaloye Julie, Schmid Patrick, Béguelin Charles, Conen Anna, Stöckle Marcel, Flepp Markus, Grube Christina, Kusejko Katharina, Kouyos Roger, Martin Eileen, Hampel Benjamin, Swiss HIV Cohort Study
High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men
Braun D, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard H, Böni J, Fehr J, Nicca D, Künzler-Heule P, Hampel B, Kouyos R, Nguyen H, Shah C, Flepp M, Stöckle M, Conen A, Béguelin C, Swiss HIV Cohort Study. High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men. Clin Infect Dis 2018
Aug 13, 2018High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men
Aug 13, 2018Clin Infect Dis 2018
Braun Dominique L, Schmid Patrick, Delaloye Julie, Rougemont Mathieu, Bernasconi Enos, Rauch Andri, Günthard Huldrych F, Böni Jürg, Fehr Jan S, Nicca Dunja, Künzler-Heule Patrizia, Hampel Benjamin, Kouyos Roger, Nguyen Huyen, Shah Cyril, Flepp Markus, Stöckle Marcel, Conen Anna, Béguelin Charles, Swiss HIV Cohort Study
Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Persons
Reinschmidt S, Kovari H, Buechel R, Kaufmann P, Weber R, Schmid P, Hauser C, Kouyos R, Tarr P, Turk T, Swiss HIV Cohort Study. Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Persons. Open Forum Infect Dis 2018; 5:ofy084.
Apr 20, 2018Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Persons
Apr 20, 2018Open Forum Infect Dis 2018; 5:ofy084
Reinschmidt Sara, Kovari Helen, Buechel Ronny R, Kaufmann Philipp, Weber Rainer, Schmid Patrick, Hauser Christoph, Kouyos Roger, Tarr Philip E, Turk Teja, Swiss HIV Cohort Study
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity
Bertels F, Cavassini M, Calmy A, Bernasconi E, Schmid P, Scherrer A, Müller V, Bonhoeffer S, Kouyos R, Regoes R, Rauch A, Battegay M, Marzel A, Leventhal G, Mitov V, Fellay J, Günthard H, Böni J, Yerly S, Klimkait T, Aubert V, Swiss HIV Cohort Study. Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity. Mol Biol Evol 2018; 35:27-37.
Jan 1, 2018Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity
Jan 1, 2018Mol Biol Evol 2018; 35:27-37
Bertels Frederic, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Schmid Patrick, Scherrer Alexandra U, Müller Viktor, Bonhoeffer Sebastian, Kouyos Roger, Regoes Roland R, Rauch Andri, Battegay Manuel, Marzel Alex, Leventhal Gabriel, Mitov Venelin, Fellay Jacques, Günthard Huldrych F, Böni Jürg, Yerly Sabine, Klimkait Thomas, Aubert Vincent, Swiss HIV Cohort Study
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
Bruggmann P, Stoeckle M, Semela D, Schmid P, Razavi H, Rauch A, Mullhaupt B, Lavanchy D, Kouyos R, Fehr J, Deltenre P, Blach S, Negro F. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss Med Wkly 2017; 147:w14543.
Nov 9, 2017Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
Nov 9, 2017Swiss Med Wkly 2017; 147:w14543
Bruggmann Philip, Stoeckle Marcel, Semela David, Schmid Patrick, Razavi Homie, Rauch Andri, Mullhaupt Beat, Lavanchy Daniel, Kouyos Roger, Fehr Jan, Deltenre Pierre, Blach Sarah, Negro Franco
Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study
Kovari H, Ledergerber B, Weber R, Bernasconi E, Stöckle M, Schmid P, Cavassini M, Rougemont M, Kouyos R, Rauch A, Swiss HIV Cohort Study. Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study. Clin Infect Dis 2017; 64:490-497.
Jan 15, 2017Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study
Jan 15, 2017Clin Infect Dis 2017; 64:490-497
Kovari Helen, Ledergerber Bruno, Weber Rainer, Bernasconi Enos, Stöckle Marcel, Schmid Patrick, Cavassini Matthias, Rougemont Mathieu, Kouyos Roger, Rauch Andri, Swiss HIV Cohort Study
Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study
Kovari H, Ledergerber B, Weber R, Bernasconi E, Stöckle M, Schmid P, Cavassini M, Rougemont M, Kouyos R, Rauch A. Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study. Clin Infect Dis 2016
Dec 12, 2016Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study
Dec 12, 2016Clin Infect Dis 2016
Kovari Helen, Ledergerber Bruno, Weber Rainer, Bernasconi Enos, Stöckle Marcel, Schmid Patrick, Cavassini Matthias, Rougemont Mathieu, Kouyos Roger, Rauch Andri
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland
Shilaih M, Kouyos R, Günthard H, Furrer H, Bernasconi E, Vernazza P, Klimkait T, Cavassini M, Aubert V, Hirsch H, Yerly S, Böni J, Schüpbach J, Scherrer A, Yang W, Marzel A, Swiss HIV Cohort Study. Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland. Sci Rep 2016; 6:27580.
Jun 14, 2016Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland
Jun 14, 2016Sci Rep 2016; 6:27580
Shilaih Mohaned, Kouyos Roger, Günthard Huldrych F, Furrer Hansjakob, Bernasconi Enos, Vernazza Pietro, Klimkait Thomas, Cavassini Matthias, Aubert Vincent, Hirsch Hans H, Yerly Sabine, Böni Jürg, Schüpbach Jörg, Scherrer Alexandra U, Yang Wan Lin, Marzel Alex, Swiss HIV Cohort Study
Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis
Scherrer A, Günthard H, Bernasconi E, Vernazza P, Calmy A, Furrer H, Battegay M, Cavassini M, Aubert V, Klimkait T, Yerly S, Böni J, Kouyos R, Yang W, von Wyl V. Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis. Clin Infect Dis 2016
Mar 8, 2016Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis
Mar 8, 2016Clin Infect Dis 2016
Scherrer Alexandra U, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Calmy Alexandra, Furrer Hansjakob, Battegay Manuel, Cavassini Matthias, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, Kouyos Roger, Yang Wan-Lin, von Wyl Viktor
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012
Yang W, Günthard H, Ledergerber B, Held L, Vernazza P, Bernasconi E, Cavassini M, Battegay M, Furrer H, Aubert V, Klimkait T, Yerly S, Shah C, Böni J, Scherrer A, Kouyos R, Swiss HIV Cohort Study. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012. J Infect Dis 2015
Jan 9, 2015Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012
Jan 9, 2015J Infect Dis 2015
Yang Wan-Lin, Günthard Huldrych F, Ledergerber Bruno, Held Leonhard, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Shah Cyril, Böni Jürg, Scherrer Alexandra U, Kouyos Roger, Swiss HIV Cohort Study